Age and research-use confirmation
Fnx Performance products are intended strictly for qualified in vitro laboratory research. For Research Use Only. Not for human or animal consumption. Not for compounding or therapeutic application.
Humanin, Mitochondrial derived peptide
The first identified mitochondrial derived peptide, cytoprotective and anti apoptotic via AKT/ERK/STAT3 signaling in preclinical neuronal and vascular models.
Mechanism of action
The first mitochondria derived peptide ever discovered, a cytoprotective, anti apoptotic signal studied for shielding neurons and blood vessels.
Also studied
Cytoprotective in neuronal models; a humanin derivative reduced amyloid-β and improved memory in an Alzheimer's mouse model.
See related compoundsPreclinical evidence for insulin sensitization and cardioprotection; no human therapeutic trials exist.
See related compoundsThe first identified mitochondrial derived peptide, encoded in the 16S rRNA region of mitochondrial DNA.
See related compoundsApplications
Alzheimer's models
Preclinical
Metabolic
Preclinical
Vascular
Preclinical
Bars indicate how far the evidence has progressed (in vitro to animal to human), not the size of any effect.
Compound data
Full profile
Neuroprotection, insulin sensitization, and cardioprotection, preclinical only. No human therapeutic trials.
Unknown in humans.
Not FDA approved; research chemical; WADA S0.
Injectable (research).
Source: Fnx Performance Peptide Research Database, a synthesis of the scientific and regulatory literature, not medical advice. Anyone considering these compounds should consult a qualified physician.
For Research Use Only. Not for human or animal consumption. These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Fnx Labs LLC | Fnx Performance
Support email: support@fnxperformancelabs.com
Support phone: 808-620-1169
Business address:
2343 W 227th St
Torrance, CA 90501
United States